Compile Data Set for Download or QSAR
maximum 50k data

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 13 hits in this display   

TargetCaspase-1(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-5(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-7(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-9(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMT: 2°CAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-3(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:To test the efficacy of caspase-3 inhibitors at the cellular level, the ability of selected compounds to inhibit the proteolytic cleavage of PARP (po...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-5(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-9(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-7(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-1(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-3(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM160794(US10167313, Compound 61 | US9045524, 61)
Affinity DataIC50: >3.33E+3nMAssay Description:Selectivity of compound 55, compound 63, compound 48, compound 57, compound 88 toward caspase-1 (pro-inflammatory group), caspase-5 (group I), caspas...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCaspase-3(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM50326094((S)-3-((S)-2-(benzyloxycarbonylamino)-3-methylbuta...)
Affinity DataIC50:  3.53E+4nMAssay Description:Inhibition of human recombinant caspase-3 expressed in Saccharomyces cerevisiae CG379 assessed as growth stimulation after 2 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-3(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM50326094((S)-3-((S)-2-(benzyloxycarbonylamino)-3-methylbuta...)
Affinity DataIC50:  1.33E+5nMAssay Description:Inhibition of human recombinant caspase 3 assessed as fluorescent 7-amido-4-methylcoumarin releaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCaspase-7(Homo sapiens (Human))
Novagenesis Foundation

US Patent
LigandPNGBDBM50326094((S)-3-((S)-2-(benzyloxycarbonylamino)-3-methylbuta...)
Affinity DataIC50: >2.00E+5nMAssay Description:Inhibition of human recombinant caspase 7 assessed as fluorescent 7-amido-4-methylcoumarin releaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed